| Leslie M Randall, MD | |
|
1300 E Marshall St, Richmond, VA 23298-5054 | |
| (804) 828-9080 | |
| (804) 828-3891 |
| Full Name | Leslie M Randall |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 23 Years |
| Location | 1300 E Marshall St, Richmond, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821054602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 0101268132 (Virginia) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 0101268132 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical College Of Virginia Hospitals | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mcv Associated Physicians | 4385542117 | 1312 |
News Archive
The Obama administration wants to spend just over half a billion dollars on Alzheimer's research next year, hoping to battle back against what could become the defining disease of the aging baby-boom generation. ... The move is part of the administration's development of the first National Alzheimer's Plan, a congressionally-ordered strategy that will combine research toward better dementia treatments with steps to help overwhelmed families to better cope today.
Apart from its direct effect on health (such as cardiovascular diseases and diabetes), obesity is increasingly suspected of playing a role in the prognosis of breast cancer and, in particular, its propensity to spread. However, no direct cause and effect relationship had been demonstrated until now. This breakthrough has finally been made through the collaborative work of two teams of researchers from Inserm, CNRS and the Université Paul Sabatier.
Ethicon, Inc., announced today that the CDC has reviewed clinical data from patients treated with BIOPATCH Protective Disk with CHG as part of its update to the 2002 guidelines for reducing risk of intravascular catheter-associated infections in the United States. In the new guidelines, use of a CHG sponge dressing is designated as a Category 1B recommendation.
CQ HealthBeat reports on a provision of the fiscal cliff law intended to encourage physicians to submit data to registries that could be a tool to promote better quality care. The Medicare NewsGroup analyzes another provision that changes how payments are calculated for end stage renal disease drugs.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
› Verified 4 days ago
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
The Obama administration wants to spend just over half a billion dollars on Alzheimer's research next year, hoping to battle back against what could become the defining disease of the aging baby-boom generation. ... The move is part of the administration's development of the first National Alzheimer's Plan, a congressionally-ordered strategy that will combine research toward better dementia treatments with steps to help overwhelmed families to better cope today.
Apart from its direct effect on health (such as cardiovascular diseases and diabetes), obesity is increasingly suspected of playing a role in the prognosis of breast cancer and, in particular, its propensity to spread. However, no direct cause and effect relationship had been demonstrated until now. This breakthrough has finally been made through the collaborative work of two teams of researchers from Inserm, CNRS and the Université Paul Sabatier.
Ethicon, Inc., announced today that the CDC has reviewed clinical data from patients treated with BIOPATCH Protective Disk with CHG as part of its update to the 2002 guidelines for reducing risk of intravascular catheter-associated infections in the United States. In the new guidelines, use of a CHG sponge dressing is designated as a Category 1B recommendation.
CQ HealthBeat reports on a provision of the fiscal cliff law intended to encourage physicians to submit data to registries that could be a tool to promote better quality care. The Medicare NewsGroup analyzes another provision that changes how payments are calculated for end stage renal disease drugs.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leslie M Randall, MD Po Box 91734, Richmond, VA 23291-1734 Ph: (804) 358-6100 | Leslie M Randall, MD 1300 E Marshall St, Richmond, VA 23298-5054 Ph: (804) 828-9080 |
News Archive
The Obama administration wants to spend just over half a billion dollars on Alzheimer's research next year, hoping to battle back against what could become the defining disease of the aging baby-boom generation. ... The move is part of the administration's development of the first National Alzheimer's Plan, a congressionally-ordered strategy that will combine research toward better dementia treatments with steps to help overwhelmed families to better cope today.
Apart from its direct effect on health (such as cardiovascular diseases and diabetes), obesity is increasingly suspected of playing a role in the prognosis of breast cancer and, in particular, its propensity to spread. However, no direct cause and effect relationship had been demonstrated until now. This breakthrough has finally been made through the collaborative work of two teams of researchers from Inserm, CNRS and the Université Paul Sabatier.
Ethicon, Inc., announced today that the CDC has reviewed clinical data from patients treated with BIOPATCH Protective Disk with CHG as part of its update to the 2002 guidelines for reducing risk of intravascular catheter-associated infections in the United States. In the new guidelines, use of a CHG sponge dressing is designated as a Category 1B recommendation.
CQ HealthBeat reports on a provision of the fiscal cliff law intended to encourage physicians to submit data to registries that could be a tool to promote better quality care. The Medicare NewsGroup analyzes another provision that changes how payments are calculated for end stage renal disease drugs.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
› Verified 4 days ago
James T Christmas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7601 Forest Ave, Suite 336, Richmond, VA 23229 Phone: 804-289-4972 Fax: 804-289-4674 | |
Katherine M Czyszczon, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 401 N 11th St, Richmond, VA 23219 Phone: 804-828-4409 Fax: 804-828-6084 | |
Stewart James Wetchler, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall Street, Richmond, VA 23298 Phone: 757-220-1246 Fax: 757-220-0835 | |
Dr. Jay E. Allard, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1300 E Marshall St, Richmond, VA 23298 Phone: 804-828-9080 Fax: 804-828-3891 | |
Dr. Ponjola Coney, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1250 E Marshall St, Ob/gyn, Richmond, VA 23298 Phone: 804-828-4409 Fax: 804-828-6084 | |
Kimberly Rhea Earhart, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7601 Forest Ave Ste 100, Richmond, VA 23229 Phone: 804-282-9479 | |
Robert E Petres, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9000 Stony Point Pkwy, Richmond, VA 23235 Phone: 804-560-8950 Fax: 804-560-7343 |